Allergy/Asthma News

Adolescents with hereditary angioedema experienced fewer attacks, improved quality of life and treatment satisfaction with lanadelumab, according to a study published in Annals of Allergy, Asthma & Immunology.

CHICAGO — A parental wellness program resonated widely with physicians navigating parenthood and improved well-being, according to two speakers at the Women in Medicine Summit.

Zoryve cream 0.15% continues to show that it can provide clinical improvement to patients with atopic dermatitis, according to a press release.

Children in Puerto Rico who grew up with a cat in their household were 68% less likely to develop asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

Veterans using inhaled corticosteroids did not face increased odds for an asthma-related health care event after short-term fine particulate matter rises, according to a research letter.

Rocatinlimab exhibited promising results in the phase 3 ROCKET HORIZON trial for the treatment of moderate to severe atopic dermatitis, Kyowa Kirin announced in a press release.

SoundHealth announced the unveiling of SONUCast, which predicts allergy responses based on the shape and size of a person’s nasal cavity and sinuses.

Researchers found a moderate association in early life antibiotic use and childhood food allergy in South Korea, according to a study published in Pediatric Allergy and Immunology.

Regeneron Pharmaceuticals Inc. and Sanofi announced the FDA approval of dupilumab for adolescents aged 12 to 17 years with chronic rhinosinusitis with nasal polyps.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.